Elisabet Figuerola Bou

Elisabet Figuerola Bou

Investigador post-doc

Research line:

Characterization and relevance of the epigenetic environment in the development of Ewing’s sarcoma

Researcher Elisabet Figuerola Bou graduated in Biomedical Sciences in 2013 from the University of Barcelona and in 2014 she obtained a master's degree in Genetics and Genomics from the same university. In May 2014, she won the first prize for young researchers Gemma Rossell i Romero from the University of Barcelona for her undergraduate work on DNA methylation in cancer in the laboratory of Dr Manel Esteller.

In 2014, she joined Dr Jaume Mora's Developmental Tumors Laboratory at the Sant Joan de Déu Developmental Tumors Laboratory as a predoctoral researcher, where she developed her doctoral dissertation on the role of epigenetics in the development of Ewing's sarcoma. In December 2019 she obtained a PhD in Biomedicine from the University of Barcelona, ​​led by Dr Jaume Mora and Dr Sara Sánchez-Molina. She has also trained in animal experimentation, scientific outreach and bioinformatics analysis for biomedical research.

She is currently working as a postdoctoral researcher in the Sarcomas and Histiocytosis group studying in depth key epigenetic targets for the development and maintenance of Ewing's sarcoma.

elisabet.figuerola@sjd.es

Professional network profiles

Last Publications

More Publications

Projects

Project name:
SGR 2022-2024_Grup de recerca en tumors del desenvolupament
Leader
Jaume Mora Graupera
Funding entities:
Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
Code
2021 SGR 01612
Starting - finishing date:
2022 - 2025
Project name:
Influencia del contexto epigenético en la edad como factor pronóstico en Ewing Sarcoma
Leader
Jaume Mora Graupera
Funding entities:
Instituto de Salud Carlos III (ISCIII)
Code
PI20/00179
Starting - finishing date:
2021 - 2023
Project name:
Virtual patient derived xenografts for tumor treatment
Leader
Jaume Mora Graupera
Funding entities:
Fundació Bancària " La Caixa"
Code
HR20-00411
Starting - finishing date:
2020 - 2023
More projects

News

  • Describe an epigenetic protein associated with the metastatic process in Ewing's Sarcoma

    A study with Dr. Jaume Mora (IRSJD) team participation and led by the Molecular Pathology of Sarcomas group of the Seville Institute of Biomedicine (IBiS) has described that the G9a protein would be associated with the development of metastases in Ewing's Sarcoma. Therefore, the overexpression of this protein would indicate an adverse prognosis.

See All news